RACK1 and cancer: Dysregulation of RACK1 expression influences tumorigenesis, potentially promoting proliferation, metastasis, invasion, and chemoresistance in various cancers, including ovarian, breast, lung, osteosarcoma, hepatocellular, cervical, and oral squamous cell carcinoma (Pi et al. 2023; Tian et al. 2023; Wang et al. 2022; Xia et al. 2023; Peng et al. 2024; Wu et al. 2020; Dan et al. 2020).